Evaluation of Efficacy and Safety of ATB-1011+ATB-1012 Co-administration for Essential Hypertension and Type II Diabetes

NCT05573477 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

248

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension
Diabetes Mellitus, Type 2

Interventions

DRUG: ATB-1011
DRUG: ATB-1012
DRUG: ATB-1013
DRUG: ATB-1011 placebo
DRUG: ATB-1012 placebo
DRUG: ATB-1013 placebo

Sponsor

Autotelicbio